youtube_live
Q3 2026 tulu • välja lastud • Aktsiakasum ületati +8,63% • Tulu ületati +3,25%
Vaadake tulemusichevron_right
NOT:ETR
Novartis AG
143,18 €
arrow_upward
+2,59%(+3,62) 1 p
29. okt, 17:35:45 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOT põhistatistika genereerimine…
Ava
141,98 €
Kõrge
145,78 €
Madal
141,98 €
Turu kapit.
327,81 mld
Keskm. maht
5,16 tuh
Maht
12,56 tuh
52 näd kõrgeim
145,78 €
52 näd madalaim
104,52 €
Töötajate arv
75 tuh
Ava
141,98 €
Kõrge
145,78 €
Madal
141,98 €
Turu kapit.
327,81 mld
Keskm. maht
5,16 tuh
Maht
12,56 tuh
52 näd kõrgeim
145,78 €
52 näd madalaim
104,52 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Seeking Alpha
·
10 tunni eest
Novartis AG 2026 Q3 - Results - Earnings Call Presentation (NYSE:NVS) 2026-10-29
Yahoo Finance
·
1 päeva eest
Novartis AG (NVS) Stock Forecasts
TradingView
·
1 päeva eest
What Novartis (NVS) Said on Its Q3 Earnings Call
GuruFocus
·
2 päeva eest
Novartis Stocks Gain With Higher Guidance but Weaker Cash Genera
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com